HIV‐1 Protease inhibitors: Their development, mechanism of action and clinical potential

This publication has 72 references indexed in Scilit:

• Human Immunodeficiency Virus Type 1 Protease Inhibitors: Evaluation of Resistance Engendered by Amino Acid Substitutions in the Enzyme's Substrate Binding Site
  Biochemistry, 1994
• Rational Design of Potent, Bioavailable, Nonpeptide Cyclic Ureas as HIV Protease Inhibitors
  Science, 1994
• STRUCTURE-BASED INHIBITORS OF HIV-1 PROTEASE
  Annual Review of Biochemistry, 1993
• Human Immunodeficiency Virus Type 1 (HIV-1) Inhibitory Interactions between Protease Inhibitor Ro 31-8959 and Zidovudine, 2',3'-Dideoxycytidine, or Recombinant Interferon- A against Zidovudine-Sensitive or -Resistant HIV-1 In Vitro
  The Journal of Infectious Diseases, 1992
• Kynostatin (KNI-227 and -272, highly potent anti-HIV agents: conformationally constrained tripeptide inhibitors of HIV protease containing allophenylnorstatine.
  CHEMICAL & PHARMACEUTICAL BULLETIN, 1992
• HIV-1 proteinase is required for synthesis of pro-viral DNA
  Biochemical and Biophysical Research Communications, 1991
• Tampering with transcription
  Nature, 1991
• Analysis of non-infectious HIV particles produced in presence of HIV proteinase inhibitor
  Archiv für die gesamte Virusforschung, 1991
• Inhibition of reverse transcriptase activity by 2′,3′-dideoxythymidine 5′-triphosphate and its derivatives modified on the 3′ position
  Biochemical and Biophysical Research Communications, 1986
• Complete nucleotide sequence of the AIDS virus, HTLV-III
  Nature, 1985